Clinical Trial Update: Prevention of Esophageal Varices by Beta-Adrenergic Blockers [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether beta-adrenergic blockers can prevent esophageal and gastric varices in patients with liver cirrhosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Varices
• Gastric Varices
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Beta-adrenergic blockers

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Esophageal and Gastric Varices, Liver Cirrhosis | Phase 3 | Status: COMPLETED